Cargando…
Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers
Oncogenic v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (K-RAS) plays a key role in the development and maintenance of pancreatic ductal adenocarcinoma (PDAC). The targeting of K-RAS would be beneficial to treat tumors whose growth depends on active K-RAS. The analysis of K-RAS genomic mutati...
Autores principales: | Mottini, Carla, Cardone, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404119/ https://www.ncbi.nlm.nih.gov/pubmed/32708716 http://dx.doi.org/10.3390/ijms21145023 |
Ejemplares similares
-
Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
por: Ferguson, Robert, et al.
Publicado: (2023) -
Identification of K‐ras Oncogene Mutations in the Pure Pancreatic Juice of Patients with Ductal Pancreatic Cancers
por: Watanabe, Hiroyuki, et al.
Publicado: (1993) -
Sensitization of Human Pancreatic Cancer Cells Harboring Mutated K-ras to Apoptosis
por: Shen, Ling, et al.
Publicado: (2012) -
Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis
por: Tao, Lian-yuan, et al.
Publicado: (2016) -
Multiple K‐ras Mutations in Hyperplasia and Carcinoma in Cases of Human Pancreatic Carcinoma
por: Matsubayashi, Hiroyuki, et al.
Publicado: (1999)